Britain USA covid-19 reports testing vaccine Britain USA

New Oxford Covid-19 vaccine trial to be run after doubts raised over research error

Reading now: 730
www.dailystar.co.uk

Oxford Covid-19 vaccine trial after questions were raised over its UK research. It comes after the US reported the vaccine's best dosage only worked well on younger people.

Oxford University's partner, pharmaceutical firm AstraZeneca, has announced the further trial. Earlier this week, representatives announced that clinical trials were up to 90% effective.

Although in June, Mirror had revealed a blunder – the group of trial participants who achieved this success rate had actually been given an initial half dose.

The trial continued and the main group who were given two full doses only recorded an effectiveness rate of 62%.It has now emerged the smaller group of less than 3,000 out of 24,000 trial participants on the half-dose-full-dose.

Read more on dailystar.co.uk
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA